Shutterstock
Q&A: Investing in Life Science
Following the DVPs first 10 investments, Emma Palmer Foster, Director of Discovery Park Ventures, and Martino Picardo, Director of DPV and Chairman of Discovery Park, share their learnings and insights into life science investing.
15 Apr 2024
Pharmaceutical Insights + Pharma Finance and Investment Insights
Chris Sutherland
Scotland’s Life Sciences Sector Poised for Growth
Speaking at an event in Edinburgh, Chris Dougray, Head of Development at CBRE Scotland, and Chris Williams, CBRE’s Head of Life Sciences, joined forces to examine the burgeoning sector’s place in Scotland.
14 Mar 2024
Pharmaceutical Insights + Pharma Finance and Investment Insights
UK biotech company responds to approval changes and R&D tax relief
Last Thursday, chancellor Jeremy Hunt announced new measures for smoother medicine approvals in the UK, increased support for R&D, and a simplified tax system for SMEs. UK biotech company, Nevrargenics shared its position on the 2023 Budget.
23 Mar 2023
Pharmaceutical Insights + Pharma Finance and Investment Insights
Vitalii Stock Shutterstock
Why invest in pharma in times of a recession?
Léone Atayi, CEO of Hybrigenics and Stemcis, discusses the importance of investing in the pharmaceutical industry amid a recession.
21 Feb 2023
Pharmaceutical Insights + Pharma Finance and Investment Insights
Smart Financing and CROs: investing in digitalisation for drug development
Sally-Anne Whybrow, healthcare business development manager, Siemens Financial Services, UK examines how smart financing can help CROs invest in financially-sustainable technology.
5 Oct 2022
Pharmaceutical Insights + Pharma Finance and Investment Insights
Q&A with Lonza: Support for biotech startups
Following on from their recent partnership with Israel Biotech Fund (IBF), EPM caught up with Lonza's Pnina Weitz on the importance of early-stage support for emerging companies, and how robust strategies early on can pave a way to commercialisation.
29 Jun 2022
Pharmaceutical Insights + Pharma Finance and Investment Insights
Garun Studios Shutterstock
Concept Life Sciences gains investments to strengthen drug discovery capabilities
Concept Life Sciences has announced key strategic appointments and advancements to further strengthen its services for the global pharmaceutical and biotechnology sectors.
16 Apr 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Thapana_Studio Shutterstock
Bormioli Pharma boosts revenues and earnings
Gerresheimer recorded a jump in revenues and earnings due to the first-time consolidation of Bormioli Pharma, which was acquired in 2024.
11 Apr 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Aelius Biotech
Scientists behind laboratory gut model raise funds for further expansion
Aelius Biotech, whose laboratory gut model is used to trial new drugs without the need for animal testing has raised £750,000 from the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures.
8 Apr 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Experience. Precision for Radiopharma Logistics. Marken
Winning the race against time with precision for critical Radiopharma shipments.
MM Group
The future of injectable pharma lies in topload packaging
In the fast-growing injectable pharmaceuticals market, which Markets & Markets projects will reach $1139.4 billion by 2029, one innovative approach stands out as particularly valuable: topload packaging design.
17 Apr 2025
Guardtech
Overcoming the challenges of constructing a new cleanroom in an old facility
Mark Wheeler, commercial director, Guardtech discusses how constructing new cleanroom facilities in older buildings can be a smart and cost-effective solution for applications looking to optimise their existing spaces.
16 Apr 2025
MAIN5
A new role for digital adoption platforms: ensuring compliant use of pharma GxP systems
Digital adoption platforms (a simple overlay to web/cloud-based systems) offer a practical solution, guiding users of each application, step by step, in correct, compliant data input. MAIN5’s Sabine Gölden assesses their potential.
15 Apr 2025
Broughton
Advancing sustainability in laboratory operations
Broughton, a analytical testing and consultancy firm, highlights its commitment to sustainability in laboratory operations by promoting environmentally responsible practices, ethical governance, and proactive maintenance strategies.
14 Apr 2025
Doro Guzenda Shutterstock
The role of automation in enhancing sterilisation processes
Ellie Gabel, Associate Editor for Revolutionized explains how cleaning and sterilisation are essential but often unoptimised processes within pharmaceutical facilities.
10 Apr 2025
Maks_lab Shutterstock
Q&A: Artiva allogeneic NK cell therapies for treating autoimmune disease
After Artiva Biotherapeutics announced the news of cryopreserved allogeneic NK cell therapies (AlloNK) for treating autoimmune disease, European Pharmaceutical Manufacturer spoke to Fred Aslan, president and CEO to learn more.
8 Apr 2025
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Experience. Precision for Radiopharma Logistics. Marken
Winning the race against time with precision for critical Radiopharma shipments.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00